ORCL CLO files Form 4: 49,988 RSUs and dividend equivalents

Rhea-AI Filing Summary

Oracle (ORCL): EVP and Chief Legal Officer reported equity awards. On 10/23/2025, the reporting person acquired 49,988 restricted stock units (RSUs) at a $0 price, which vest in four equal annual installments beginning on the first anniversary of the grant. The filing also records 142.94 dividend equivalents accrued on earned RSUs granted on 11/05/2022, calculated using Oracle’s closing price of $280.07 on 10/23/2025, the dividend payment date.

Following these transactions, direct derivative holdings reported were 159,157.199 after the dividend-equivalent entry and 49,988 for the new RSU grant. Each RSU represents the right to receive one share of common stock at settlement.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Levey Stuart

Role EVP, Chief Legal Officer

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Unit	142.94	$280.07	$40K
Grant/Award	Restricted Stock Unit	49,988	$0.00	--

Holdings After Transaction: Restricted Stock Unit — 159,157.199 shares (Direct)

Footnotes (1)

1. Represents dividend equivalents accrued with respect to earned restricted stock units that were granted on November 5, 2022, which the reporting person has elected to defer. The number of dividend equivalents reported was calculated using Oracle's closing stock price on Otober 23, 2025 ($280.07), the date on which dividends were paid on Oracle's common stock. Each restricted stock unit represents the contingent right to receive, at settlement, one share of common stock. The restricted stock units vest in four equal annual installments, beginning on the first anniversary of the date of grant.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Levey Stuart

(Last) (First) (Middle)

C/O DELPHI ASSET MGMT CORPORATION

200 S. VIRGINIA ST., SUITE 625

(Street)

RENO NV 89501

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ORACLE CORP [ ORCL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Chief Legal Officer

3. Date of Earliest Transaction (Month/Day/Year)
10/23/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	(1)	10/23/2025		A		142.94		(1)	(1)	Common Stock	142.94	$280.07	159,157.199	D
Restricted Stock Unit	(2)	10/23/2025		A		49,988		(3)	(3)	Common Stock	49,988	$0	49,988	D

Explanation of Responses:

1. Represents dividend equivalents accrued with respect to earned restricted stock units that were granted on November 5, 2022, which the reporting person has elected to defer. The number of dividend equivalents reported was calculated using Oracle's closing stock price on Otober 23, 2025 ($280.07), the date on which dividends were paid on Oracle's common stock.

2. Each restricted stock unit represents the contingent right to receive, at settlement, one share of common stock.

3. The restricted stock units vest in four equal annual installments, beginning on the first anniversary of the date of grant.

	/s/ Aimee Weast by Aimee Weast, Attorney in Fact for Stuart Levey (POA filed 11/08/22)	10/27/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.